IP Library Patent Application 15292810
Patent Application
App. No. 15/292,810

FULVESTRANT COMPOSITIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/292,810
Abstract

The inventive subject matter provides ready to inject fulvestrant compositions with improved solubility and stability, and methods for preparing the same. Contemplated compositions include fulvestrant at a concentration of greater than 100 mg/ml, and maintain degradation of the fulvestrant at a level of less than 5 wt % when stored over at least three months at 25° C.

Claims (34)

1 . A ready to inject fulvestrant composition, comprising:

fulvestrant present in the composition at a concentration of greater than 100 mg/ml;

diethylene glycol monoethyl ether or an alkyl derivative thereof as a solvent;

between 1-5 v/v % of a co-solvent; and

wherein the composition maintains a degradation of fulvestrant at a level of less than 5 wt % when stored over at least three months at 25° C.

2 . The composition of claim 1 , wherein the co-solvent is benzyl alcohol.

3 . The composition of claim 1 , wherein fulvestrant is present at a concentration of at least 125 mg/ml.

4 . The composition of claim 3 , wherein fulvestrant is present at a concentration of at least 150 mg/ml.

5 . The composition of claim 1 , further comprising a second co-solvent present in the composition at no more than 50 v/v %.

6 . The composition of claim 5 , wherein the second co-solvent comprises castor oil and acts as a release rate modifier.

7 . The composition of claim 1 , wherein the composition is formulated to maintain degradation of fulvestrant at a level of less than 2 wt % when stored over at least three months at 25° C.

8 . The composition of claim 1 , wherein the composition is formulated to maintain degradation of fulvestrant at a level of less than 5 wt % when stored over at least three months at 2-8° C.

9 . The composition of claim 1 , wherein the composition is provided in a multi-use container.

10 . The composition of claim 1 , wherein the diethylene glycol monoethyl ether or the alkyl derivative thereof is present in the composition at more than 40 v/v %.

11 . A method of manufacturing a ready to inject fulvestrant composition containing article, comprising:

formulating a liquid composition including fulvestrant such that the formulation exhibits less than 5 wt % degradation of the fulvestrant when stored over at least three months at 25° C.;

wherein the liquid composition comprises diethylene glycol monoethyl ether or an alkyl derivative thereof as a solvent, fulvestrant at a concentration greater than 100 mg/ml, and between 1-5 v/v % of a co-solvent; and

packaging the liquid formulation in the article.

12 . The method of claim 11 , wherein the co-solvent is benzyl alcohol.

13 . The method of claim 11 , wherein fulvestrant is present at a concentration of at least 125 mg/ml.

14 . The method of claim 13 , wherein fulvestrant is present at a concentration of at least 150 mg/ml.

15 . The method of claim 11 , wherein the liquid composition further comprises a second co-solvent present in the composition at no more than 50 v/v %.

16 . The method of claim 15 , wherein the second co-solvent comprises castor oil and acts as a release rate modifier.

17 . The method of claim 11 , wherein formulating comprises formulating the liquid composition such that the formulation exhibits less than 2 wt % degradation when stored over at least three months at 25° C.

18 . The method of claim 11 , wherein formulating comprises formulating the liquid composition such that the formulation remains clear and colorless when stored over at least three months at 25° C.

19 . The method of claim 11 , wherein the article is a multi-use container, and wherein packaging comprises packaging the liquid formulation in an amount that includes at least 500 mg fulvestrant.

20 . The method of claim 11 , wherein diethylene glycol monoethyl ether or the alkyl derivative thereof is present in the composition at more than 40 v/v %.

21 . A ready to inject fulvestrant composition, comprising:

fulvestrant present in the composition at a concentration of greater than 100 mg/ml;

diethylene glycol monoethyl ether or an alkyl derivative thereof as a solvent;

wherein the composition has a viscosity of less than 80 centipoise; and

wherein the composition maintains a degradation of the fulvestrant at a level of less than 5 wt % when stored over at least three months at 25° C.

22 . The composition of claim 21 , further comprising between 1-5 v/v % of a co-solvent.

23 . The composition of claim 21 , wherein the co-solvent is benzyl alcohol.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVE PROPERTY NUMBERS PREVIOUSLY RECORDED AT REEL: 057183 FRAME: 0825. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 18, 2021
From: NEVAKAR INC.
To: NEVAKAR INJECTABLES INC.
Reel/Frame 057251/0432 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2016
From: PATEL, DINESH SHANTILAL; PATEL, SACHIN DINESH; KURANI, SHASHIKANT PRABHUDAS; PATEL, MADHAVLAL GOVINDLAL; SOPPIMATH, KUMARESH, DR
To: THEMIS MEDICARE LIMITED; NEVAKAR LLC
Reel/Frame 040552/0174 →